Article
Part 2 of this program delves deeper into glucagon-like peptide-1, or GLP-1, and its therapeutic potential in type 2 diabetes. Click here to learn more.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
2 Commerce Drive
Cranbury, NJ 08512